demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Sinopharm Beijing (BBIBP-CorV) Ashmawy Rearte Xia ... Sultan Kanokudom

0 studies excluded by filtering options 2